Hepatoprotective Agent

Known as: Hepatoprotectants, Hepatoprotective Agents, Hepatoprotective Drugs 
Agents administered before, with, or after cancer therapy to reduce or prevent damage or toxicity to the liver. (NCI)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1964-2016
012319642016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Plant-derived active ingredients with hepatoprotective activity have been used extensively in the treatment of various liver… (More)
Is this relevant?
2017
2017
Acetaminophen (APAP, paracetamol) overdose has been the most frequent cause of drug-induced liver failure. APAP-induced liver… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2016
2016
BACKGROUND AND AIM Hepatoprotectants are routinely prescribed in China to prevent anti-tuberculosis drug-induced liver injury… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2016
2016
Background: Syzygium aromaticum is commonly known as clove. It is being used since centuries for different purposes in different… (More)
  • table I
Is this relevant?
2015
2015
BACKGROUND Glycyrrhizin, silymarin, and ursodeoxycholic acid are widely used hepatoprotectants for the treatment of liver… (More)
Is this relevant?
2015
2015
CONTEXT To systematically evaluate the effects of hepatoprotective agents, when delivered either alone or in combination with… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
PURPOSE The 2 direct-acting antiviral combination (2D) of ombitasvir and paritaprevir (coadministered with ritonavir) is being… (More)
  • figure 1
  • figure 2
  • table I
  • figure 3
  • figure 4
Is this relevant?
Review
2014
Review
2014
Liver is the largest and most vital organ of the body. It is also called as metabolic ‘engine room’ of the body. Most of the… (More)
  • figure 1
  • figure 6
  • figure 7
  • figure 8
  • figure 10
Is this relevant?
2003
2003
An open clinical trial was conducted during 6 months from February to August 2002 in children diagnosed with hepatomegaly… (More)
  • figure 2
  • figure 4
  • figure 6
  • figure 7
Is this relevant?